Phase III Study of KX-826 With Adult Male Patients With AGA

Clinical trial NCT06126965 · UNKNOWN

Trial details

NCT number: NCT06126965
Sponsor: Suzhou Kintor Pharmaceutical Inc,
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Androgenetic Alopecia

Start date: 2021-12-29
Primary completion: 2024-05-31
Enrollment: 740

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.